Entasis Therapeutics Limited
Records under this name other than the patents Entasis Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 5 of 5 · Back to Entasis Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,623,014 | Beta-Lactamase Inhibitor Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,238,661 | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections Lapsed on the fee record Ended Mar 26, 2023 · USPTO record | Lapsed on the fee record | Ended Mar 26, 2023 | USPTO record |
| US 7,439,253 | Novel Heterocyclic Compounds, Their Preparation and Their Use as Medicaments, in Particular as Antibacterials and Beta-Lactamase Inhibitors Lapsed on the fee record Ended Oct 21, 2020 · Medium confidence | Lapsed on the fee record | Ended Oct 21, 2020 | Medium confidence |
| US 8,148,540 | Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents Lapsed on the fee record Ended Apr 3, 2020 · USPTO record | Lapsed on the fee record | Ended Apr 3, 2020 | USPTO record |
| US 7,288,549 | Novel Heterocyclic Compounds, Method for Preparing Same and Use Thereof as Medicines, in Particular as Antibacterial Agents Lapsed on the fee record Ended Oct 30, 2019 · Medium confidence | Lapsed on the fee record | Ended Oct 30, 2019 | Medium confidence |